Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
Recruiting · NCT05769868 · Registry updated 2024-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments | Fibrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Recruiting | Phase 3 | 2024-10-01 | NCT05769868 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | 17 |
| Instituto de Salud Carlos III | 59 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clínic de Barcelona | Barcelona | Spain | 25 |
| Hospital Clínico Universitario de Salamanca | Salamanca | Spain | 3 |
| Hospital General Universitario Gregorio Marañón | Madrid | Spain | 25 |
| Hospital Universitari i Politècnic La Fe | Valencia | Spain | 12 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 1 |
| Hospital Universitario La Paz | Madrid | Spain | 46 |